Wake Forest Baptist Comprehensive Cancer Center is a clinical research site located in Winston-Salem, North Carolina, United States 27157.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Wake Forest Baptist Comprehensive Cancer Center has participated in 74 clinical trials with 28 currently active.
Therapeutic areas: Leukemia, Myeloid, Acute, Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer Stage.
Sponsors: Delta-Fly Pharma, Inc., Wake Forest University Health Sciences, Oblato, Inc..
Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Wake Forest Baptist Comprehensive Cancer Center has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wake Forest Baptist Comprehensive Cancer Center has 74 clinical trials on record, with 28 currently active. Their work covers Leukemia, Myeloid, Acute, Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer Stage.
Yes — Wake Forest Baptist Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.